Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
0,00040 US$
0,00%
(0,00) 1D
14 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
0,00 US$
High
0,00 US$
Low
0,00 US$
Mkt. cap
12,88 ათ.
Avg. vol.
16,14 ათ.
Volume
3,75 ათ.
52-wk high
0,02 US$
52-wk low
0,00 US$
Beta
1,66
Shares outstanding
26,83 მლნ.
No. of employees
68
Open
0,00 US$
High
0,00 US$
Low
0,00 US$
Mkt. cap
12,88 ათ.
Avg. vol.
16,14 ათ.
Volume
3,75 ათ.
52-wk high
0,02 US$
52-wk low
0,00 US$
Beta
1,66
Shares outstanding
26,83 მლნ.
No. of employees
68
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
Sector-
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2023
მარ. 2024
ივნ. 2024
სექ. 2024
Revenue
386,00 ათ.
-
-
-
Cost of goods sold
-
-
-
20,53 მლნ.
Cost of revenue
-
-
-
20,53 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,66 მლნ.
Operating expense
-
-
-
5,66 მლნ.
Total operating expenses
-
-
-
26,18 მლნ.
Operating income
-
-
-
-26,18 მლნ.
Other non operating income
-
-
-
20,30 მლნ.
EBT including unusual items
-
-
-
-6,40 მლნ.
EBT excluding unusual items
-
-
-
-6,40 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,40 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-2,22
-0,10
-0,59
-0,16
Interest and investment income
-
-
-
793,00 ათ.
Interest expense
-
-
-
-1,31 მლნ.
Net interest expenses
-
-
-
-519,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-25,86 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები